Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02275507 · ClinicalTrials.gov registry record
Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery
A clinical trial, sponsored by Stony Brook University.
- Completed
- Registry status
- 50
- Enrollment target
NCT02275507 is a clinical trial that has completed, run by Stony Brook University. The registered enrollment target is 50 participants.
The verdict
NCT02275507 has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the normal hemoglobin curve during cesarean delivery and for the first 24 hours after surgery to aid in the creation of an algorithm to detect life-threatening bleeding earlier.
Interventions
- DEVICE Masimo Rainbow Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-10-15 |
| Est. Completion | 2016-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02275507
The ClinicalTrials.gov registry entry for NCT02275507 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo Rainbow Sensor is the first listed.
NCT02275507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02275507 about?
NCT02275507 is a clinical study titled "Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery". The purpose of this study is to determine the normal hemoglobin curve during cesarean delivery and for the first 24 hours after surgery to aid in the creation of an algorithm to detect life-threatening bleeding earlier.
What is the current status of trial NCT02275507?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-10-15. Estimated completion is 2016-10-30.
What interventions are being tested in trial NCT02275507?
The interventions under investigation include: Masimo Rainbow Sensor (DEVICE).
Who is sponsoring clinical trial NCT02275507?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.